Patent · US Active

Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof

US11020400B2 · kind B2 · utility

0Cited by

5References

15Claims

0Family size

Assignee

ArQule Inc. · US

Inventors

Jean-Marc Lapierre · Pelham, US
Sudharshan Eathiraj · North Andover, US
Nivedita Namdev · Westford, US
Brian Schwartz · Woodbridge, US
Yusuke Ota · Tokyo, JP
Takayuki Momose · Tokyo, JP
Tomoyuki Tsunemi · Tokyo, JP
Hiroaki Inagaki · Tokyo, JP
Kiyoshi Nakayama · Tokyo, JP

Key dates

Filing date	Nov 4, 2019
Grant date	Jun 1, 2021
Priority date	—
Expiry date	Nov 4, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.